pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search

calendar

27,085 catalysts · 17,272 approval · 3,896 device 510k · 2,448 grant · 1,413 device recall · 1,196 device pma · 860 recall

★ save view↓export CSV
next 91 dayslessmore
MonWedFri
2026-08-31: 0 catalysts2026-09-01: 1 catalyst2026-09-02: 0 catalysts2026-09-03: 1 catalyst2026-09-04: 0 catalysts2026-09-05: 0 catalysts2026-09-06: 0 catalysts2026-09-07: 0 catalysts2026-09-08: 0 catalysts2026-09-09: 0 catalysts2026-09-10: 0 catalysts2026-09-11: 0 catalysts2026-09-12: 0 catalysts2026-09-13: 0 catalysts2026-09-14: 0 catalysts2026-09-15: 0 catalysts2026-09-16: 0 catalysts2026-09-17: 0 catalysts2026-09-18: 0 catalysts2026-09-19: 0 catalysts2026-09-20: 0 catalysts2026-09-21: 0 catalysts2026-09-22: 0 catalysts2026-09-23: 2 catalysts2026-09-24: 0 catalysts2026-09-25: 0 catalysts2026-09-26: 0 catalysts2026-09-27: 0 catalysts2026-09-28: 0 catalysts2026-09-29: 0 catalysts2026-09-30: 1 catalyst2026-10-01: 0 catalysts2026-10-02: 0 catalysts2026-10-03: 0 catalysts2026-10-04: 0 catalysts2026-10-05: 0 catalysts2026-10-06: 0 catalysts2026-10-07: 0 catalysts2026-10-08: 2 catalysts2026-10-09: 0 catalysts2026-10-10: 0 catalysts2026-10-11: 0 catalysts2026-10-12: 0 catalysts2026-10-13: 1 catalyst2026-10-14: 1 catalyst2026-10-15: 0 catalysts2026-10-16: 0 catalysts2026-10-17: 0 catalysts2026-10-18: 0 catalysts2026-10-19: 1 catalyst2026-10-20: 2 catalysts2026-10-21: 2 catalysts2026-10-22: 2 catalysts2026-10-23: 1 catalyst2026-10-24: 0 catalysts2026-10-25: 0 catalysts2026-10-26: 1 catalyst2026-10-27: 8 catalysts2026-10-28: 12 catalysts2026-10-29: 21 catalysts2026-10-30: 4 catalysts2026-10-31: 0 catalysts2026-11-01: 0 catalysts2026-11-02: 9 catalysts2026-11-03: 18 catalysts2026-11-04: 22 catalysts2026-11-05: 37 catalysts2026-11-06: 2 catalysts2026-11-07: 0 catalysts2026-11-08: 0 catalysts2026-11-09: 1 catalyst2026-11-10: 0 catalysts2026-11-11: 0 catalysts2026-11-12: 0 catalysts2026-11-13: 0 catalysts2026-11-14: 0 catalysts2026-11-15: 0 catalysts2026-11-16: 0 catalysts2026-11-17: 0 catalysts2026-11-18: 0 catalysts2026-11-19: 0 catalysts2026-11-20: 0 catalysts2026-11-21: 0 catalysts2026-11-22: 0 catalysts2026-11-23: 0 catalysts2026-11-24: 0 catalysts2026-11-25: 0 catalysts2026-11-26: 0 catalysts2026-11-27: 0 catalysts2026-11-28: 0 catalysts2026-11-29: 0 catalysts
view
agendamonth
sort
soonestlatesttypesponsoralpha
to 2025-12-09×clear all
type
  • approval17,272
  • device 510k3,896
  • grant2,448
  • device recall1,413
  • device pma1,196
  • recall860
therapy area

no tagged catalysts yet

Week of Jun 22, 2020

19
›Jun 22, 2020approval2262d agoXPOVIO (SELINEXOR) — FDA approvalselinexor

Sponsor: KARYOPHARM THERAPS. Form: TABLET. Route: ORAL

full page →selinexor →fda approvals ↗
›Jun 23, 2020approval2261d agoMEKINIST (TRAMETINIB DIMETHYL SULFOXIDE) — FDA approvalSpexotras

Sponsor: NOVARTIS. Form: TABLET. Route: ORAL

full page →Spexotras →fda approvals ↗
›Jun 23, 2020approval2261d agoOPDIVO (NIVOLUMAB) — FDA approvalnivolumab

Sponsor: BRISTOL MYERS SQUIBB. Form: INJECTABLE. Route: INJECTION

full page →nivolumab →fda approvals ↗
›Jun 23, 2020approval2261d agoBUPRENORPHINE HYDROCHLORIDE — FDA approvalIGC Pharma, Inc.

Sponsor: PH HEALTH. Form: INJECTABLE. Route: INJECTION

full page →fda approvals ↗
›Jun 23, 2020approval2261d agoBUPRENORPHINE HYDROCHLORIDE — FDA approvalIGC Pharma, Inc.

Sponsor: PH HEALTH. Form: INJECTABLE. Route: INJECTION

full page →fda approvals ↗
›Jun 23, 2020approval2261d agoBUPRENORPHINE HYDROCHLORIDE — FDA approvalIGC Pharma, Inc.

Sponsor: AM REGENT. Form: INJECTABLE. Route: INJECTION

full page →fda approvals ↗
›Jun 23, 2020approval2261d agoBUPRENORPHINE HYDROCHLORIDE — FDA approvalIGC Pharma, Inc.

Sponsor: AM REGENT. Form: INJECTABLE. Route: INJECTION

full page →fda approvals ↗
›Jun 24, 2020approval2260d agoKEYTRUDA (PEMBROLIZUMAB) — FDA approvalpembrolizumab

Sponsor: MERCK SHARP DOHME. Form: SOLUTION. Route: INTRAVENOUS

full page →pembrolizumab →fda approvals ↗
›Jun 24, 2020approval2260d agoKEYTRUDA (PEMBROLIZUMAB) — FDA approvalpembrolizumab

Sponsor: MERCK SHARP DOHME. Form: SOLUTION. Route: INTRAVENOUS

full page →pembrolizumab →fda approvals ↗
›Jun 25, 2020approval2259d agoDIVALPROEX SODIUM — FDA approvaldivalproex sodium DR

Sponsor: RISING. Form: CAPSULE, DELAYED REL PELLETS. Route: ORAL

full page →divalproex sodium DR →fda approvals ↗
›Jun 25, 2020approval2259d agoDIVALPROEX SODIUM — FDA approvaldivalproex sodium DR

Sponsor: RISING. Form: CAPSULE, DELAYED REL PELLETS. Route: ORAL

full page →divalproex sodium DR →fda approvals ↗
›Jun 25, 2020approval2259d agoDIVALPROEX SODIUM — FDA approvaldivalproex sodium DR

Sponsor: RISING. Form: CAPSULE, DELAYED REL PELLETS. Route: ORAL

full page →divalproex sodium DR →fda approvals ↗
›Jun 25, 2020approval2259d agoDIVALPROEX SODIUM — FDA approvaldivalproex sodium DR

Sponsor: RISING. Form: CAPSULE, DELAYED REL PELLETS. Route: ORAL

full page →divalproex sodium DR →fda approvals ↗
›Jun 25, 2020approval2259d agoDIVALPROEX SODIUM — FDA approvaldivalproex sodium DR

Sponsor: RISING. Form: CAPSULE, DELAYED REL PELLETS. Route: ORAL

full page →divalproex sodium DR →fda approvals ↗
›Jun 25, 2020approval2259d agoDIVALPROEX SODIUM — FDA approvaldivalproex sodium DR

Sponsor: RISING. Form: CAPSULE, DELAYED REL PELLETS. Route: ORAL

full page →divalproex sodium DR →fda approvals ↗
›Jun 25, 2020approval2259d agoDIVALPROEX SODIUM — FDA approvaldivalproex sodium DR

Sponsor: RISING. Form: CAPSULE, DELAYED REL PELLETS. Route: ORAL

full page →divalproex sodium DR →fda approvals ↗
›Jun 25, 2020approval2259d agoLIBTAYO (CEMIPLIMAB-RWLC) — FDA approvalcemiplimab

Sponsor: REGENERON PHARMACEUTICALS. Form: INJECTABLE. Route: INTRAVENOUS

full page →cemiplimab →fda approvals ↗
›Jun 25, 2020approval2259d agoFINTEPLA (FENFLURAMINE HYDROCHLORIDE) — FDA approvalfenfluramine hydrochloride

Sponsor: UCB INC. Form: SOLUTION. Route: ORAL

full page →fenfluramine hydrochloride →fda approvals ↗
›Jun 26, 2020approval2258d agoGAMIFANT (EMAPALUMAB-LZSG) — FDA approvalSobi Inc

Sponsor: NOVIMMUNE S.A.. Form: INJECTABLE. Route: INJECTION

full page →fda approvals ↗

Week of Jun 29, 2020

4
›Jun 29, 2020approval2255d agoKEYTRUDA (PEMBROLIZUMAB) — FDA approvalpembrolizumab

Sponsor: MERCK SHARP DOHME. Form: SOLUTION. Route: INTRAVENOUS

full page →pembrolizumab →fda approvals ↗
›Jun 29, 2020approval2255d agoFINGOLIMOD HYDROCHLORIDE — FDA approvalEzra Ventures LLC

Sponsor: CHARTWELL RX. Form: CAPSULE. Route: ORAL

full page →fda approvals ↗
›Jul 1, 2020approval2253d agoATORVASTATIN CALCIUM — FDA approvalSciegen Pharmaceuticals Inc

Sponsor: SCIEGEN PHARMS. Form: TABLET. Route: ORAL

full page →fda approvals ↗
›Jul 1, 2020approval2253d agoLEVORPHANOL TARTRATE — FDA approvalLEVORPHANOL TARTRATE

Sponsor: NOVITIUM PHARMA. Form: TABLET. Route: ORAL

full page →LEVORPHANOL TARTRATE →fda approvals ↗

Week of Jul 6, 2020

3
›Jul 10, 2020approval2244d agoERLEADA (APALUTAMIDE) — FDA approvalapalutamide

Sponsor: JANSSEN BIOTECH. Form: TABLET. Route: ORAL

full page →apalutamide →fda approvals ↗
›Jul 10, 2020approval2244d agoICLUSIG (PONATINIB HYDROCHLORIDE) — FDA approvalTakeda Pharmaceuticals USA Inc

Sponsor: TAKEDA PHARMS USA. Form: TABLET. Route: ORAL

full page →fda approvals ↗
›Jul 10, 2020approval2244d agoRINVOQ (UPADACITINIB) — FDA approvalupadacitinib tartrate ER

Sponsor: ABBVIE. Form: TABLET, EXTENDED RELEASE. Route: ORAL

full page →upadacitinib tartrate ER →fda approvals ↗

Week of Jul 13, 2020

17
›Jul 13, 2020approval2241d agoTREMFYA (GUSELKUMAB) — FDA approvalguselkumab

Sponsor: JANSSEN BIOTECH. Form: INJECTABLE. Route: INJECTION

full page →guselkumab →fda approvals ↗
›Jul 14, 2020approval2240d agoJULUCA (DOLUTEGRAVIR SODIUM) — FDA approvalViiV Healthcare Company

Sponsor: VIIV HLTHCARE. Form: TABLET. Route: ORAL

full page →fda approvals ↗
›Jul 14, 2020approval2240d agoAMPHETAMINE SULFATE — FDA approvalAurolife Pharma LLC

Sponsor: DR REDDYS LABS SA. Form: TABLET. Route: ORAL

full page →fda approvals ↗
›Jul 15, 2020approval2239d agoLIDOCAINE HYDROCHLORIDE AND EPINEPHRINE (EPINEPHRINE) — FDA approvaladrenaline

Sponsor: HOSPIRA. Form: INJECTABLE. Route: INJECTION

full page →adrenaline →fda approvals ↗
›Jul 15, 2020approval2239d agoLIDOCAINE HYDROCHLORIDE AND EPINEPHRINE (EPINEPHRINE) — FDA approvaladrenaline

Sponsor: HOSPIRA. Form: INJECTABLE. Route: INJECTION

full page →adrenaline →fda approvals ↗
›Jul 15, 2020approval2239d agoLIDOCAINE HYDROCHLORIDE AND EPINEPHRINE (EPINEPHRINE) — FDA approvaladrenaline

Sponsor: HOSPIRA. Form: INJECTABLE. Route: INJECTION

full page →adrenaline →fda approvals ↗
›Jul 15, 2020approval2239d agoLIDOCAINE HYDROCHLORIDE AND EPINEPHRINE (EPINEPHRINE) — FDA approvaladrenaline

Sponsor: HOSPIRA. Form: INJECTABLE. Route: INJECTION

full page →adrenaline →fda approvals ↗
›Jul 15, 2020approval2239d agoLIDOCAINE HYDROCHLORIDE AND EPINEPHRINE (EPINEPHRINE) — FDA approvaladrenaline

Sponsor: HOSPIRA. Form: INJECTABLE. Route: INJECTION

full page →adrenaline →fda approvals ↗
›Jul 15, 2020approval2239d agoLIDOCAINE HYDROCHLORIDE AND EPINEPHRINE (EPINEPHRINE) — FDA approvaladrenaline

Sponsor: HOSPIRA. Form: INJECTABLE. Route: INJECTION

full page →adrenaline →fda approvals ↗
›Jul 15, 2020approval2239d agoLIDOCAINE HYDROCHLORIDE AND EPINEPHRINE (EPINEPHRINE) — FDA approvaladrenaline

Sponsor: HOSPIRA. Form: INJECTABLE. Route: INJECTION

full page →adrenaline →fda approvals ↗
›Jul 15, 2020approval2239d agoLIDOCAINE HYDROCHLORIDE AND EPINEPHRINE (EPINEPHRINE) — FDA approvaladrenaline

Sponsor: HOSPIRA. Form: INJECTABLE. Route: INJECTION

full page →adrenaline →fda approvals ↗
›Jul 15, 2020approval2239d agoLIDOCAINE HYDROCHLORIDE AND EPINEPHRINE (EPINEPHRINE) — FDA approvaladrenaline

Sponsor: HOSPIRA. Form: INJECTABLE. Route: INJECTION

full page →adrenaline →fda approvals ↗
›Jul 15, 2020approval2239d agoLIDOCAINE HYDROCHLORIDE AND EPINEPHRINE (EPINEPHRINE) — FDA approvaladrenaline

Sponsor: HOSPIRA. Form: INJECTABLE. Route: INJECTION

full page →adrenaline →fda approvals ↗
›Jul 15, 2020approval2239d agoLIDOCAINE HYDROCHLORIDE AND EPINEPHRINE (EPINEPHRINE) — FDA approvaladrenaline

Sponsor: HOSPIRA. Form: INJECTABLE. Route: INJECTION

full page →adrenaline →fda approvals ↗
›Jul 15, 2020approval2239d agoLIDOCAINE HYDROCHLORIDE AND EPINEPHRINE (EPINEPHRINE) — FDA approvaladrenaline

Sponsor: HOSPIRA. Form: INJECTABLE. Route: INJECTION

full page →adrenaline →fda approvals ↗
›Jul 16, 2020approval2238d agoCABOMETYX (CABOZANTINIB S-MALATE) — FDA approvalcabozantinib s-malate

Sponsor: EXELIXIS INC. Form: TABLET. Route: ORAL

full page →cabozantinib s-malate →fda approvals ↗
›Jul 17, 2020approval2237d agoBUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDE (BUPRENORPHINE HYDROCHLORIDE) — FDA approvalBUPRENORPHINE HYDROCHLORIDE

Sponsor: WES PHARMA INC. Form: TABLET. Route: SUBLINGUAL

full page →BUPRENORPHINE HYDROCHLORIDE →fda approvals ↗

Week of Jul 20, 2020

5
›Jul 21, 2020approval2233d agoSTIVARGA (REGORAFENIB) — FDA approvalBayer AG

Sponsor: BAYER HLTHCARE. Form: TABLET. Route: ORAL

full page →fda approvals ↗
›Jul 21, 2020approval2233d agoGABAPENTIN — FDA approvalGABAPENTIN

Sponsor: ACTAVIS ELIZABETH. Form: CAPSULE. Route: ORAL

full page →GABAPENTIN →fda approvals ↗
›Jul 21, 2020approval2233d agoGABAPENTIN — FDA approvalGABAPENTIN

Sponsor: ACTAVIS ELIZABETH. Form: CAPSULE. Route: ORAL

full page →GABAPENTIN →fda approvals ↗
›Jul 23, 2020approval2231d agoIMATINIB MESYLATE — FDA approvalInhibikase Therapeutics, Inc.

Sponsor: EUGIA PHARMA. Form: TABLET. Route: ORAL

full page →fda approvals ↗
›Jul 24, 2020approval2230d agoANASTROZOLE — FDA approvalStason Pharmaceuticals Inc

Sponsor: EUGIA PHARMA. Form: TABLET. Route: ORAL

full page →fda approvals ↗

Week of Jul 27, 2020

2
›Jul 28, 2020approval2226d agoALDACTONE (SPIRONOLACTONE) — FDA approvalALDACTONE

Sponsor: PFIZER. Form: TABLET. Route: ORAL

full page →ALDACTONE →fda approvals ↗
›Jul 29, 2020approval2225d agoSTELARA (USTEKINUMAB) — FDA approvalJOHNSON & JOHNSON

Sponsor: CENTOCOR ORTHO BIOTECH INC. Form: INJECTABLE. Route: INJECTION

full page →fda approvals ↗
← prev
page 231 of 542
next →
$PFE28.46+1.79%
$KPTI
$ABBV256.42+0.37%
$EXEL54.64+0.35%
$IGC0.2670+0.41%
$REGN799.08+0.62%
$BMY66.81+0.35%
$IGC0.2670+0.41%
$IGC0.2670+0.41%
$IGC0.2670+0.41%
$IGC0.2670+0.41%
$NVS152.42-0.90%
$JNJ268.04+0.85%
$IKT2.3100-4.15%